Anteris Technologies Ltd. (AU:AVR) has released an update.
Anteris Technologies Ltd. has expanded its capital base by issuing 12,000 new ordinary shares at $10 each, raising $120,000. These shares were issued under a specific section of the Corporations Act, without the need for a disclosure statement. Anteris, a structural heart company, is known for its innovative medical devices, including its leading DurAVRTM THV, which is expected to address unmet needs in the treatment of aortic stenosis.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
